Who is Acquandas? Its thin film manufacturing goes beyond Synchron

This nitinol thin film actuator made by Acquandas with a film thickness of 50 µm can pull 550 times its own weight. [Image courtesy of Acquandas]

Acquandas is a thin-film device manufacturer that’s now partially owned by brain-computer interface developer Synchron.

Rodrigo Lima de Miranda founded Acquandas in 2012 based on microsystem technology he developed for his doctoral thesis, where he was trying to develop a shape memory material made with thin-film deposition.

The Kiel, Germany-based contract manufacturer now uses the Nanolab cleanroom facilities at Kiel University and is growing its team of around 22 employees.

Beyond neurotech applications like Synchron’s Stentrode, the Acquandas technology has promising potential for cardiac ablation, renal denervation, opthamology, nerve stimulation, passive microimplants, microneedles, and smart actuators and springs, Lima de Miranda said …

Read more
  • 0

BCI developer Synchron buys stake in thin film maker Acquandas

The Stentrode endovascular electrode array for brain-computer interface [Image courtesy of Synchron]Synchron, a developer of brain-computer interface (BCI) technology, today announced the acquisition of an equity stake in Acquandas.

Acquandas, a German-based company, specializes in high-precision components for healthcare and other industries.

The company bases its metallic components on state-of-the-art microsystem technology processes. It fabricates thin film components for applications in medical devices, including micro-patterned nitinol thin films. They feature high structure resolution, high geometrical complexity, strong biocompatibility and improved mechanical properties.

“As we pioneer functional endovascular neurotechnology, this investment strengthens our technology innovation and supply chain for our unique product offerings, beginning with brain-computer interfaces,” said Tom Oxley, Synchron founder and CEO.

As part of the transaction, O…

Read more
  • 0